Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Portraits show women's hairlines have moved forward over time, suggesting changes in the occurrence of frontal hair loss.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Frontal fibrosing alopecia and vitiligo might be linked by similar immune issues.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Hair restoration techniques improved rapidly in 2004, leading to more natural results, with a shift to microscopic methods and diverse treatments including medical management, cloning, and surgical techniques. Laser hair removal was also mentioned.

Hair restoration techniques improved rapidly in 2004, leading to more natural results, with a shift to microscopic methods and diverse treatments including medical management, cloning, and surgical techniques. Laser hair removal was also mentioned.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Cow placenta lotion works like minoxidil 2% for female hair loss, with fewer side effects.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Hair gets thinner and grayer with age, and density decreases more in men on top and in women on top and back.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Different ethnic groups have unique hair growth patterns, with African hair growing slower and less dense, Asian hair growing fast but sparse, and Caucasian hair being densest; men are more likely to experience hair loss than women.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

Androgenetic alopecia causes hair thinning in women, affecting their quality of life.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Men with lichen planopilaris had earlier onset than women, and treatment usually improved the condition.

Patients with androgenetic alopecia often have abnormal lipid levels, so they should be screened and advised on lifestyle changes to prevent heart issues.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.